From Early October, Jnetics, a charity dedicated to the management and prevention of Jewish Genetic Disorders, will increase its testing panel from nine to 47 conditions.

Nicole Gordon CEO EXPLAINED, “This is a hugely exciting development in the history of Jnetics. The panel has been increased to include further conditions prevalent in the Ashkenazi community, and for the first time we have a number of conditions prevalent in the Sephardi and Mizrahi communities “ We are now encouraging any young Jewish adults with at least one Jewish grandparent to come forward and be tested “

“The additional conditions have been carefully selected based on a number of inclusion criteria and under the guidance of Jnetic’s Scientific and Medical advisory committee. All the genetic conditions are recessive , Guila Vaz Mouyal Research and Development Manager, explained, meaning that there is only a 1 in 4 chance of having an affected child if both parents carry the faulty gene. Carriers of the faulty gene are NOT affected.

The test itself is a simple spit test, which since the onset of Covid, is carried out in a totally virtual way, via 5 simple steps. Jnetics works in conjunction with the NHS, ensuring that if a couple are both found to be carriers of the same genetic conditions, they can be streamlined into the NHS system.

Jnetics currently screens Year 12 students in all 9 Jewish secondary schools across the country, Jewish students at a UK university and through the Jnetics clinic where young couples thinking about starting a family are encouraged to get tested, For further information on where and how to get tested please visit

“Currently, so many health issues are beyond our control. Screening for Jewish Genetic Disorders and managing the risk of having a child with one of the severe life threatening and or life shortening genetic disorders that we screen for is not “- Nicole Gordon , CEO concluded